Home > Studies


	!Title could not be found! !Content could not be found! !Link could not be found!

	!Title could not be found! !Content could not be found! !Link could not be found!
	Browse Trials by Conditions We have also organized the clinical trial by Health Conditions. Choose a condition from the drop-down menu to start your search.

Studies

Barrow Neurological Institute of St. Joseph's Hospital and Medical Center, Phoenix, Arizona

Print This Page for Your Doctor	New Search
	1 through 2 of 2

Sort By: Trial Title | Age Range | Last Updated

Title begins with... A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

	Human Recombinant Fibroblast Growth Factor-1 (FGF-1141), for the Treatment of Subjects with Severe Coronary Heart Disease, a Double-blind, Placebo-controlled, Dose-varying Study (ACORD) Keyword(s): Coronary Disease, Cornoary Heart Disease, Myocardial Ischemia, Coronary Arteriosclerosis, Heart Disease Location: Chandler, Arizona Status: Open and Not enrolling subjects Last Updated Tuesday, March 03, 2009 Age Range 18 + Summary Treatment for no-option heart patients with coronary artery disease. Procedure includes the injection into the heart of a protein growth factor, administered by the Cordis Corp. MyoStar injection catheter, to stimulate the growth of blood vessels around blocked coronary arteries. Primary Sponsor CardioVascular BioTherapeutics Inc. More Information Email !Title could not be found! !Phone could not be found! Contact Us Form
	Read more Adult Stem Cells Can Repair Damaged Heart 12/4/2009 12:00:00 AM (MST) Small study found they spurred blood vessel growth after heart attack Hide Article Adult Stem Cells Can Repair Damaged Heart 12/4/2009 12:00:00 AM (MST) Adult Stem Cells Can Repair Damaged Heart FRIDAY, Dec. 4 (HealthDay News) -- Adult stem cells appear to help repair heart attack damage, a new study shows. The phase 1 study of 53 patients found that stem cells from donor bone marrow promoted the growth of new blood vessels in heart tissue damaged by heart attack. The patients received the stem cell injections within 10 days of having a heart attack. During follow-up, they were compared to patients who had received a placebo injection. After six months, those who got the stem cells were four times more likely to be better off overall, pumped more blood with each heartbeat, and had one-quarter as many irregular heartbeats, when compared to the placebo group. There also were no serious side effects with the stem cell treatment, according to the report published in the Dec. 8 issue of the Journal of the American College of Cardiology. This is the strongest evidence so far that adult stem cells can repair heart attack damage, the Rush University Medical Center researchers said. It had been believed that only embryonic stem cells could turn into heart or other organ cells. "The results point to a promising new treatment for heart attack patients that could reduce [death] and lessen the need for heart transplants," Dr. Gary Schaer, head of the Rush Cardiac Catheterization Laboratory, said in a news release from the university. More information The U.S. National Heart, Lung, and Blood Institute has more about heart attack. SOURCE: Rush University Medical Center, news release, Dec. 2, 2009 Hide Article

	Human Recombinant Fibroblast Growth Factor-1 (FGF-1141), for the Treatment of Subjects with Severe Coronary Heart Disease, a Double-blind, Placebo-controlled, Dose-varying Study (ACORD) Keyword(s): Coronary Disease, Cornoary Heart Disease, Myocardial Ischemia, Coronary Arteriosclerosis, Heart Disease Location: Gilbert, Arizona Status: Open and Not enrolling subjects Last Updated Tuesday, March 03, 2009 Age Range 18 + Summary Treatment for no-option heart patients with coronary artery disease. Procedure includes the injection into the heart of a protein growth factor, administered by the Cordis Corp. MyoStar injection catheter, to stimulate the growth of blood vessels around blocked coronary arteries. Primary Sponsor CardioVascular BioTherapeutics Inc. More Information Email !Title could not be found! !Phone could not be found! Contact Us Form
	Read more Adult Stem Cells Can Repair Damaged Heart 12/4/2009 12:00:00 AM (MST) Small study found they spurred blood vessel growth after heart attack Hide Article Adult Stem Cells Can Repair Damaged Heart 12/4/2009 12:00:00 AM (MST) Adult Stem Cells Can Repair Damaged Heart FRIDAY, Dec. 4 (HealthDay News) -- Adult stem cells appear to help repair heart attack damage, a new study shows. The phase 1 study of 53 patients found that stem cells from donor bone marrow promoted the growth of new blood vessels in heart tissue damaged by heart attack. The patients received the stem cell injections within 10 days of having a heart attack. During follow-up, they were compared to patients who had received a placebo injection. After six months, those who got the stem cells were four times more likely to be better off overall, pumped more blood with each heartbeat, and had one-quarter as many irregular heartbeats, when compared to the placebo group. There also were no serious side effects with the stem cell treatment, according to the report published in the Dec. 8 issue of the Journal of the American College of Cardiology. This is the strongest evidence so far that adult stem cells can repair heart attack damage, the Rush University Medical Center researchers said. It had been believed that only embryonic stem cells could turn into heart or other organ cells. "The results point to a promising new treatment for heart attack patients that could reduce [death] and lessen the need for heart transplants," Dr. Gary Schaer, head of the Rush Cardiac Catheterization Laboratory, said in a news release from the university. More information The U.S. National Heart, Lung, and Blood Institute has more about heart attack. SOURCE: Rush University Medical Center, news release, Dec. 2, 2009 Hide Article